Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Ureteral Neoplasms × LHRH, lysine(6)-doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Prostatic Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Gemcitabine 2 Cisplatin 2 pembrolizumab 1 enfortumab vedotin 1 copanlisib 1 avelumab 1 LHRH, lysine(6)-doxorubicin 1 Carboplatin 1 ALT-801 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01234519 2018-03-15

A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy

AEterna Zentaris

Phase 1/2 Terminated

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡